WOLFSPEED, INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that WOLFSPEED, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2013 | Jun 30, 2013 | $375.01M | Aug 28, 2013 |
| FY2013 | Mar 31, 2013 | $348.93M | Aug 28, 2013 |
| FY2013 | Dec 30, 2012 | $346.29M | Aug 28, 2013 |
| FY2013 | Sep 23, 2012 | $315.75M | Aug 28, 2013 |
| FY2012 | Jun 24, 2012 | $306.76M | Aug 21, 2012 |
| FY2012 | Mar 25, 2012 | $284.80M | Aug 21, 2012 |
| FY2012 | Dec 25, 2011 | $304.12M | Aug 21, 2012 |
| FY2012 | Sep 25, 2011 | $268.98M | Aug 21, 2012 |
| FY2012 | Jun 26, 2011 | $243.03M | Aug 21, 2012 |
| FY2012 | Mar 27, 2011 | $219.17M | Aug 21, 2012 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 29, 2025 | $757.60M | Aug 26, 2025 |
| FY2025 | Jun 30, 2024 | $807.20M | Aug 26, 2025 |
| FY2025 | Jun 25, 2023 | $758.50M | Aug 26, 2025 |
| FY2024 | Jun 26, 2022 | $572.10M | Aug 22, 2024 |
| FY2021 | Jun 27, 2021 | $145.80M | Aug 18, 2021 |
| FY2021 | Mar 28, 2021 | $137.30M | Aug 18, 2021 |
| FY2021 | Dec 27, 2020 | $127.00M | Aug 18, 2021 |
| FY2021 | Sep 27, 2020 | $115.50M | Aug 18, 2021 |
| FY2021 | Jun 28, 2020 | $108.40M | Aug 18, 2021 |
| FY2021 | Mar 29, 2020 | $113.90M | Aug 18, 2021 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 29, 2025 | ($121.60M) | Aug 26, 2025 |
| FY2025 | Jun 30, 2024 | $77.40M | Aug 26, 2025 |
| FY2025 | Jun 25, 2023 | $242.90M | Aug 26, 2025 |
| FY2024 | Jun 26, 2022 | $208.10M | Aug 22, 2024 |
| FY2021 | Jun 27, 2021 | $43.80M | Aug 18, 2021 |
| FY2021 | Mar 28, 2021 | $44.00M | Aug 18, 2021 |
| FY2021 | Dec 27, 2020 | $41.30M | Aug 18, 2021 |
| FY2021 | Sep 27, 2020 | $35.50M | Aug 18, 2021 |
| FY2021 | Jun 28, 2020 | $29.10M | Aug 18, 2021 |
| FY2021 | Mar 29, 2020 | $41.30M | Aug 18, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 29, 2025 | ($1.61B) | Aug 26, 2025 |
| FY2025 | Jun 30, 2024 | ($864.20M) | Aug 26, 2025 |
| FY2025 | Jun 25, 2023 | ($329.90M) | Aug 26, 2025 |
| FY2023 | Jun 26, 2022 | ($200.90M) | Aug 23, 2023 |
| FY2021 | Jun 27, 2021 | ($147.60M) | Aug 18, 2021 |
| FY2021 | Mar 28, 2021 | ($108.90M) | Aug 18, 2021 |
| FY2021 | Dec 27, 2020 | ($83.00M) | Aug 18, 2021 |
| FY2021 | Sep 27, 2020 | ($184.40M) | Aug 18, 2021 |
| FY2021 | Jun 28, 2020 | ($39.50M) | Aug 18, 2021 |
| FY2021 | Mar 29, 2020 | ($60.10M) | Aug 18, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 29, 2025 | ($1.33B) | Aug 26, 2025 |
| FY2025 | Jun 30, 2024 | ($445.30M) | Aug 26, 2025 |
| FY2025 | Jun 25, 2023 | ($311.80M) | Aug 26, 2025 |
| FY2024 | Jun 26, 2022 | ($203.10M) | Aug 22, 2024 |
| FY2023 | Jun 27, 2021 | ($313.90M) | Aug 23, 2023 |
| FY2022 | Jun 28, 2020 | ($224.10M) | Aug 22, 2022 |
| FY2021 | Jun 30, 2019 | ($93.50M) | Aug 18, 2021 |
| FY2020 | Jun 24, 2018 | ($28.00M) | Aug 19, 2020 |
| FY2019 | Jun 25, 2017 | ($20.10M) | Aug 21, 2019 |
| FY2018 | Jun 26, 2016 | ($10.47M) | Aug 20, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 29, 2025 | $175.10M | Aug 26, 2025 |
| FY2025 | Jun 30, 2024 | $201.90M | Aug 26, 2025 |
| FY2025 | Jun 25, 2023 | $165.70M | Aug 26, 2025 |
| FY2024 | Jun 26, 2022 | $142.60M | Aug 22, 2024 |
| FY2023 | Jun 27, 2021 | $177.80M | Aug 23, 2023 |
| FY2022 | Jun 28, 2020 | $152.00M | Aug 22, 2022 |
| FY2021 | Jun 30, 2019 | $121.10M | Aug 18, 2021 |
| FY2020 | Jun 24, 2018 | $127.30M | Aug 19, 2020 |
| FY2019 | Jun 25, 2017 | $113.80M | Aug 21, 2019 |
| FY2018 | Jun 26, 2016 | $168.85M | Aug 20, 2018 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 29, 2025 | $190.50M | Aug 26, 2025 |
| FY2025 | Jun 30, 2024 | $246.40M | Aug 26, 2025 |
| FY2025 | Jun 25, 2023 | $214.30M | Aug 26, 2025 |
| FY2024 | Jun 26, 2022 | $183.00M | Aug 22, 2024 |
| FY2023 | Jun 27, 2021 | $181.60M | Aug 23, 2023 |
| FY2022 | Jun 28, 2020 | $181.70M | Aug 22, 2022 |
| FY2021 | Jun 30, 2019 | $168.90M | Aug 18, 2021 |
| FY2020 | Jun 24, 2018 | $170.30M | Aug 19, 2020 |
| FY2019 | Jun 25, 2017 | $145.70M | Aug 21, 2019 |
| FY2018 | Jun 26, 2016 | $283.05M | Aug 20, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 29, 2025 | ($711.70M) | Aug 26, 2025 |
| FY2025 | Jun 30, 2024 | ($725.60M) | Aug 26, 2025 |
| FY2025 | Jun 25, 2023 | ($142.60M) | Aug 26, 2025 |
| FY2024 | Jun 26, 2022 | ($154.20M) | Aug 22, 2024 |
| FY2023 | Jun 27, 2021 | ($125.50M) | Aug 23, 2023 |
| FY2022 | Jun 28, 2020 | ($29.00M) | Aug 22, 2022 |
| FY2021 | Jun 30, 2019 | $202.30M | Aug 18, 2021 |
| FY2020 | Jun 24, 2018 | $173.50M | Aug 19, 2020 |
| FY2019 | Jun 25, 2017 | $220.50M | Aug 21, 2019 |
| FY2018 | Jun 26, 2016 | $203.32M | Aug 20, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 29, 2025 | $1.27B | Aug 26, 2025 |
| FY2025 | Jun 30, 2024 | $2.27B | Aug 26, 2025 |
| FY2025 | Jun 25, 2023 | $949.60M | Aug 26, 2025 |
| FY2024 | Jun 26, 2022 | $636.80M | Aug 22, 2024 |
| FY2023 | Jun 27, 2021 | $570.50M | Aug 23, 2023 |
| FY2022 | Jun 28, 2020 | $229.90M | Aug 22, 2022 |
| FY2021 | Jun 30, 2019 | $124.70M | Aug 18, 2021 |
| FY2020 | Jun 24, 2018 | $172.30M | Aug 19, 2020 |
| FY2019 | Jun 25, 2017 | $86.90M | Aug 21, 2019 |
| FY2018 | Jun 26, 2016 | $120.02M | Aug 20, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 29, 2025 | $6.85B | Aug 26, 2025 |
| FY2025 | Jun 30, 2024 | $7.98B | Aug 26, 2025 |
| FY2024 | Jun 25, 2023 | $6.59B | Aug 22, 2024 |
| FY2023 | Jun 26, 2022 | $3.92B | Aug 23, 2023 |
| FY2022 | Jun 27, 2021 | $3.45B | Aug 22, 2022 |
| FY2021 | Jun 28, 2020 | $3.23B | Aug 18, 2021 |
| FY2020 | Jun 30, 2019 | $2.82B | Aug 19, 2020 |
| FY2019 | Jun 24, 2018 | $2.64B | Aug 21, 2019 |
| FY2018 | Jun 25, 2017 | $2.65B | Aug 20, 2018 |
| FY2017 | Jun 26, 2016 | $2.77B | Aug 23, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 29, 2025 | ($447.10M) | Aug 26, 2025 |
| FY2025 | Jun 30, 2024 | $882.10M | Aug 26, 2025 |
| FY2025 | Jun 25, 2023 | $1.62B | Aug 26, 2025 |
| FY2025 | Jun 26, 2022 | $2.44B | Aug 26, 2025 |
| FY2022 | Jun 27, 2021 | $2.12B | Aug 22, 2022 |
| FY2021 | Jun 28, 2020 | $2.08B | Aug 18, 2021 |
| FY2020 | Jun 30, 2019 | $2.04B | Aug 19, 2020 |
| FY2019 | Jun 24, 2018 | $2.07B | Aug 21, 2019 |
| FY2018 | Jun 25, 2017 | $2.22B | Aug 20, 2018 |
| FY2018 | Jun 26, 2016 | $2.37B | Aug 20, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 29, 2025 | $0 | Aug 26, 2025 |
| FY2025 | Jun 30, 2024 | $359.20M | Aug 26, 2025 |
| FY2025 | Jun 25, 2023 | $359.20M | Aug 26, 2025 |
| FY2023 | Jun 26, 2022 | $359.20M | Aug 23, 2023 |
| FY2022 | Jun 27, 2021 | $359.20M | Aug 22, 2022 |
| FY2021 | Jun 28, 2020 | $349.70M | Aug 18, 2021 |
| FY2020 | Jun 30, 2019 | $530.00M | Aug 19, 2020 |
| FY2019 | Jun 24, 2018 | $530.00M | Aug 21, 2019 |
| FY2018 | Jun 25, 2017 | $618.83M | Aug 20, 2018 |
| FY2017 | Jun 26, 2016 | $618.83M | Aug 23, 2017 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 29, 2025 | ($4.54B) | Aug 26, 2025 |
| FY2025 | Jun 30, 2024 | ($2.93B) | Aug 26, 2025 |
| FY2024 | Jun 25, 2023 | ($2.06B) | Aug 22, 2024 |
| FY2023 | Jun 26, 2022 | ($1.76B) | Aug 23, 2023 |
| FY2022 | Jun 27, 2021 | ($1.56B) | Aug 22, 2022 |
| FY2021 | Jun 28, 2020 | ($1.04B) | Aug 18, 2021 |
| FY2020 | Jun 30, 2019 | ($847.50M) | Aug 19, 2020 |
| FY2019 | Jun 24, 2018 | ($482.70M) | Aug 21, 2019 |
| FY2018 | Jun 25, 2017 | ($202.74M) | Aug 20, 2018 |
| FY2017 | Jun 26, 2016 | ($613.0K) | Aug 23, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 29, 2025 | $467.20M | Aug 26, 2025 |
| FY2025 | Jun 30, 2024 | $1.05B | Aug 26, 2025 |
| FY2024 | Jun 25, 2023 | $1.76B | Aug 22, 2024 |
| FY2023 | Jun 26, 2022 | $449.50M | Aug 23, 2023 |
| FY2022 | Jun 27, 2021 | $379.00M | Aug 22, 2022 |
| FY2021 | Jun 28, 2020 | $448.80M | Aug 18, 2021 |
| FY2020 | Jun 30, 2019 | $500.50M | Aug 19, 2020 |
| FY2019 | Jun 24, 2018 | $118.90M | Aug 21, 2019 |
| FY2018 | Jun 25, 2017 | $132.60M | Aug 20, 2018 |
| FY2018 | Jun 26, 2016 | $166.15M | Aug 20, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 29, 2025 | $6.54B | Aug 26, 2025 |
| FY2025 | Jun 30, 2024 | $6.16B | Aug 26, 2025 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 29, 2025 | (11) | Aug 26, 2025 |
| FY2025 | Jun 30, 2024 | (6) | Aug 26, 2025 |
| FY2025 | Jun 25, 2023 | (2) | Aug 26, 2025 |
| FY2024 | Jun 26, 2022 | (1) | Aug 22, 2024 |
| FY2021 | Jun 27, 2021 | (1) | Aug 18, 2021 |
| FY2021 | Mar 28, 2021 | 0 | Aug 18, 2021 |
| FY2021 | Dec 27, 2020 | 0 | Aug 18, 2021 |
| FY2021 | Sep 27, 2020 | (1) | Aug 18, 2021 |
| FY2021 | Jun 28, 2020 | 0 | Aug 18, 2021 |
| FY2021 | Mar 29, 2020 | 0 | Aug 18, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 29, 2025 | (11) | Aug 26, 2025 |
| FY2025 | Jun 30, 2024 | (6) | Aug 26, 2025 |
| FY2025 | Jun 25, 2023 | (2) | Aug 26, 2025 |
| FY2024 | Jun 26, 2022 | (1) | Aug 22, 2024 |
| FY2021 | Jun 27, 2021 | (1) | Aug 18, 2021 |
| FY2021 | Mar 28, 2021 | 0 | Aug 18, 2021 |
| FY2021 | Dec 27, 2020 | 0 | Aug 18, 2021 |
| FY2021 | Sep 27, 2020 | (1) | Aug 18, 2021 |
| FY2021 | Jun 28, 2020 | 0 | Aug 18, 2021 |
| FY2021 | Mar 29, 2020 | 0 | Aug 18, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 29, 2025 | 155.64M | Aug 26, 2025 |
| FY2025 | Jun 30, 2024 | 126.41M | Aug 26, 2025 |
| FY2024 | Jun 25, 2023 | 124.79M | Aug 22, 2024 |
| FY2023 | Jun 26, 2022 | 123.80M | Aug 23, 2023 |
| FY2022 | Jun 27, 2021 | 115.69M | Aug 22, 2022 |
| FY2021 | Jun 28, 2020 | 109.23M | Aug 18, 2021 |
| FY2020 | Jun 30, 2019 | 106.57M | Aug 19, 2020 |
| FY2019 | Jun 24, 2018 | 101.49M | Aug 21, 2019 |
| FY2018 | Jun 25, 2017 | 97.67M | Aug 20, 2018 |
| FY2017 | Jun 26, 2016 | 100.83M | Aug 23, 2017 |